Accelerating Compound Discovery.
Ensuring Regulatory Compliance.
The first Swiss-made AI-Assisted platform purpose-built to transform R&D and compliance for the Nutraceutical, Cosmetic, and Medical Device sectors.
Reduce time-to-market by up to 70% with integrated in-silico discovery and source-tethered, audit-ready evidence curation. HubMed™ is the digital scientific partner that turns overwhelming data into actionable evidence.
Overcoming the Limits of Traditional R&D
R&D teams in specialized life sciences face unprecedented bottlenecks.
HubMed solves the 'fragmentation gap' between initial discovery and final audit readiness. By moving beyond manual screening and black-box automation, we transform scientific literature into traceable, reproducible, and audit-ready evidence—keeping your experts in complete control.
The HubMed™ Ecosystem:
Bridging the Gap from Lab to Market
Medea™ | AI-Assisted Clinical Evaluation & EU MDR Compliance
End-to-end clinical evaluation management with a 70% reduction in bottlenecks.
AI-Assisted SOTA & CER Analysis: streamline Comparative Effectiveness Research and State of the Art (SOTA) mapping using the standardized PICO framework.
Continuous Literature Monitoring: leverage machine-reading across PubMed, Embase, and specialized databases to eliminate selection bias and gaps in evidence.
MDR & IVDR Audit-Readiness: generate compliant, natively structured technical documentation with unmatched precision to mitigate Notified Body risks.
70% Resource Optimization: accelerate literature screening and appraisal, saving up to 29 hours per CER.
Adam™ | Accelerating Discovery
In-Silico Early Discovery & Molecule Screening. Designed to:
Identify promising bioactive compounds with intelligent screening.
Optimize hits through advanced receptorial and toxicological safety profiling.
Transition from "predicting" to "creating" innovative molecular leads
10x faster identification of promising active ingredients
60–80% reduction in candidate screening costs
Swiss Precision Meets AI Innovation
We don't just provide software; we deliver defensible, human-controlled AI workspaces built on Swiss quality and strict regulatory rigor.
Swiss-Made Reliability
Swiss data privacy standards, highest security, and audit-proof software reliability.
AI-Assisted Evidence
Human-in-the-loop AI delivering 100% traceable and reproducible scientific evidence. HubMed acts as an intelligent research assistant, distilling complex data so your experts can focus on high-value scientific decision-making.
End-to-End Integration
Unifying preclinical compound discovery (Adam™) with EU MDR clinical evaluation (Medea™).
Maximum Security
A "secure vault" for your intellectual property, ensuring GDPR compliance and Swiss data privacy standards.
Specialized AI for Your Industry
Cosmetics
In-silico safety profiling and innovative skincare ingredient discovery — the sustainable alternative to traditional testing
Contract Research Organization (CRO)
Enhancing operational efficiency, profitability, and audit-readiness ('NB-ready' documentation) for large-scale research organizations.
Evidence-Based Results: Driving R&D Excellence
Used by leading R&D teams to navigate complex therapeutic avenues and regulatory landscapes.
0 Major Non-Conformities
Defensible, source-tethered CER files built to pass Notified Body scrutiny on the first attempt.
70% Reduction
in literature monitoring and document preparation time.
Zero-Gaps
in regulatory submissions through standardized PICO methodology.
Accelerated GTM
Bringing innovative ingredients to market faster than ever before.
Latest articles from our blog
Explore the latest research, insights, and technological trends driving the next generation of Nutraceuticals and Medical Devices. From in-silico molecule discovery to ai assisted MDR compliance, stay informed with practical tips and expert analysis designed to accelerate your R&D lifecycle.
Frequently asked questions
Here are some common questions about our company.
HubMed bridges the gap between preclinical innovation and regulatory compliance through two integrated AI engines: Adam™ (automating molecular design and candidate screening 10x faster) and Medea™ (cutting CER drafting and literature appraisal time by up to 70%). By uniting discovery and compliance in a single workflow, teams bring products to market faster while significantly reducing operational costs.
No. While traditional AI tools focus almost exclusively on Pharma, HubMed is purpose-built for the underserved MedTech, Cosmetics, and Nutraceuticals sectors. We address the unique challenges of these industries—such as EU MDR 2017/745 compliance, bioactivity claim substantiation, and rapid active ingredient optimization.
HubMed operates on a strict Human-in-the-Loop and Source-Tethered framework. Our AI never generates speculative data or "hallucinates." Every single data point, literature summary, and appraisal score is directly linked and traceable back to its original scientific source (e.g., MEDLINE/PubMed, Embase). Your senior experts maintain 100% control and final sign-off over every dossier.
Medea™ natively structures documentation according to EU MDR Annex XIV standards. It eliminates common "Rounds of Questions" (RAQs) by automating systematic literature screening (PICO criteria), evaluating risk of bias, and ensuring seamless alignment between your ISO 14971 Risk Management File and Post-Market Clinical Follow-up (PMCF) data.
As a Swiss-made platform, security is our cornerstone. All data is protected in a "vault" environment that meets the highest Swiss data privacy standards and GDPR.
Our regulatory engine is continuously updated in real-time to reflect the latest MDCG (Medical Device Coordination Group) guidance notes, mandatory EUDAMED module rollouts, and legacy device transition timelines. This guarantees that your technical documentation and literature surveillance remain permanently compliant and audit-ready.
Ready to Revolutionize Your R&D Workflow?
Join the future of ingredient innovation and regulatory excellence.